In AML cell lines and patient samples, MKC-3946 also effectively blocked cleavage of XBP1 mRNA and exerted a cytotoxic effect, in a manner similar to that of STF-083010, HNA, and toyocamycin [124]. Here, XBP1 is linked to acute myeloid leukemia.